Shenzhen Glory Medical Co.,Ltd.
Символ: 002551.SZ
SHZ
3.25
CNYПазарна цена днес
-8.2638
Съотношение P/E
0.1056
Коефициент PEG
2.75B
MRK Cap
- 0.00%
Доходност на DIV
Shenzhen Glory Medical Co.,Ltd. (002551-SZ) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 3716.69 | 920.1 | 1088.9 | 1264.3 | ||||||||||||||||
balance-sheet.row.short-term-investments | 1464.91 | 434.9 | 292.5 | 121.1 | ||||||||||||||||
balance-sheet.row.net-receivables | 2979.55 | 653.9 | 871.2 | 904.1 | ||||||||||||||||
balance-sheet.row.inventory | 1624.24 | 416.8 | 375.9 | 343.7 | ||||||||||||||||
balance-sheet.row.other-current-assets | 141.11 | 37.4 | 57.4 | 99 | ||||||||||||||||
balance-sheet.row.total-current-assets | 8461.58 | 2028.2 | 2393.4 | 2611.1 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2144.79 | 556 | 637.6 | 785.1 | ||||||||||||||||
balance-sheet.row.goodwill | 49.43 | 12.4 | 68.6 | 68.6 | ||||||||||||||||
balance-sheet.row.intangible-assets | 1552.63 | 510 | 275.6 | 217.2 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1602.06 | 522.4 | 344.2 | 285.8 | ||||||||||||||||
balance-sheet.row.long-term-investments | -879.47 | -288.1 | 90.1 | 110.9 | ||||||||||||||||
balance-sheet.row.tax-assets | 527.04 | 137.4 | 93.1 | 86.1 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 4971.02 | 1304.6 | 1414.8 | 1182.3 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 8365.44 | 2232.3 | 2579.8 | 2450.2 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 16827.02 | 4260.5 | 4973.2 | 5061.3 | ||||||||||||||||
balance-sheet.row.account-payables | 1352.04 | 380 | 447.1 | 466.9 | ||||||||||||||||
balance-sheet.row.short-term-debt | 145.59 | 41.5 | 61.1 | 178.7 | ||||||||||||||||
balance-sheet.row.tax-payables | 324.1 | 81.2 | 97.8 | 80.9 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 1165.59 | 290.6 | 331.1 | 301.2 | ||||||||||||||||
Deferred Revenue Non Current | 332.72 | 84.3 | 75 | 76.3 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 1.35 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 584 | 237.1 | 7.5 | 5.1 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1508.13 | 379 | 417.4 | 377.4 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-liab | 4989.02 | 1261.2 | 1526.8 | 1415.9 | ||||||||||||||||
balance-sheet.row.preferred-stock | 132.36 | 65.2 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 3379.06 | 844.8 | 844.7 | 820.3 | ||||||||||||||||
balance-sheet.row.retained-earnings | 2346.89 | 578.7 | 829.7 | 772.1 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 2545.39 | -65.2 | 42.5 | 68.7 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 2665.42 | 1333.6 | 1403.8 | 1320.4 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 11069.11 | 2757.1 | 3120.7 | 2981.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 16827.02 | 4260.5 | 4973.2 | 5061.3 | ||||||||||||||||
balance-sheet.row.minority-interest | 768.89 | 242.2 | 325.7 | 664.1 | ||||||||||||||||
balance-sheet.row.total-equity | 11838 | 2999.3 | 3446.4 | 3645.4 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 16827.02 | - | - | - | ||||||||||||||||
Total Investments | 585.44 | 146.8 | 382.6 | 232 | ||||||||||||||||
balance-sheet.row.total-debt | 1311.18 | 332.1 | 392.2 | 479.9 | ||||||||||||||||
balance-sheet.row.net-debt | -940.6 | -153.2 | -404.2 | -663.4 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -270.9 | -327.9 | 88 | 369.9 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 74.59 | 125 | 76.7 | 55.1 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -44.4 | -1.2 | -1.1 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 44.4 | 1.2 | 1.1 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 100.36 | -90.4 | 57.9 | 30.6 | ||||||||||||||||
cash-flows.row.account-receivables | 156.27 | 156.3 | 49.6 | 116.2 | ||||||||||||||||
cash-flows.row.inventory | -55.92 | -55.9 | -38.6 | -41 | ||||||||||||||||
cash-flows.row.account-payables | 0 | -146.4 | 48.1 | -43.5 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -44.4 | -1.2 | -1.1 | ||||||||||||||||
cash-flows.row.other-non-cash-items | -308.64 | 389.7 | 20 | 41.9 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -404.59 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -39.16 | -57.3 | -430 | -254.2 | ||||||||||||||||
cash-flows.row.acquisitions-net | 14.07 | 1.5 | 0.5 | -67.1 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -837.59 | -865.4 | -1221 | -295.2 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 969.27 | 732.6 | 1087.2 | 473.3 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0.01 | 11.7 | -0.1 | -5.4 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 106.6 | -176.8 | -563.4 | -148.6 | ||||||||||||||||
cash-flows.row.debt-repayment | -106.68 | -88.8 | -248.4 | -204.2 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0.19 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.19 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | -46.77 | -164 | -30.3 | -49.8 | ||||||||||||||||
cash-flows.row.other-financing-activites | -14.86 | 61.7 | 287 | 338.9 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -168.31 | -191.1 | 8.3 | 84.9 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -11.73 | 6.1 | 4.7 | -20.3 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -195.96 | -265.4 | -307.7 | 413.6 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 2095.56 | 387.2 | 652.6 | 960.4 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2291.52 | 652.6 | 960.4 | 546.8 | ||||||||||||||||
cash-flows.row.operating-cash-flow | -404.59 | 96.5 | 242.6 | 497.5 | ||||||||||||||||
cash-flows.row.capital-expenditure | -39.16 | -57.3 | -430 | -254.2 | ||||||||||||||||
cash-flows.row.free-cash-flow | -443.75 | 39.2 | -187.4 | 243.3 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1254.49 | 1275.7 | 1790.3 | 2267.3 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 1036.9 | 1053.8 | 1427.4 | 1572.6 | ||||||||||||||||
income-statement-row.row.gross-profit | 217.59 | 221.9 | 362.9 | 694.7 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 44.68 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 45.85 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -10.77 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 121.73 | 115.4 | 100.6 | 121.4 | ||||||||||||||||
income-statement-row.row.operating-expenses | 199.65 | 228.4 | 267.9 | 311.5 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 1236.55 | 1282.3 | 1695.3 | 1884 | ||||||||||||||||
income-statement-row.row.interest-income | 4.28 | 6.9 | 5.2 | 8.7 | ||||||||||||||||
income-statement-row.row.interest-expense | 4.59 | 4.4 | 7.2 | 17 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -10.77 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 9.2 | -385.2 | -37.7 | -1.8 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 121.73 | 115.4 | 100.6 | 121.4 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 9.2 | -385.2 | -37.7 | -1.8 | ||||||||||||||||
income-statement-row.row.interest-expense | 4.59 | 4.4 | 7.2 | 17 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 384.56 | 125 | 76.7 | 67.9 | ||||||||||||||||
income-statement-row.row.ebitda-caps | 54.75 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -329.81 | 0.8 | 126.7 | 370.3 | ||||||||||||||||
income-statement-row.row.income-before-tax | -320.61 | -384.4 | 89.1 | 368.5 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -55.13 | -56.5 | 1 | -1.5 | ||||||||||||||||
income-statement-row.row.net-income | -270.9 | -327.9 | 88 | 369.9 |
Често задавани въпроси
Какво е Shenzhen Glory Medical Co.,Ltd. (002551.SZ) общи активи?
Shenzhen Glory Medical Co.,Ltd. (002551.SZ) общите активи са 4260470294.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 609397464.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -0.525.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -0.525.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.216.
Какъв е общият приход на предприятието?
Общият приход е -0.263.
Каква е Shenzhen Glory Medical Co.,Ltd. (002551.SZ) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -327902476.040.
Какъв е общият дълг на фирмата?
Общият дълг е 332058494.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 228422734.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 655096782.000.